MARC details
| 000 -LEADER |
| fixed length control field |
01908nam a22003497a 4500 |
| 001 - CONTROL NUMBER |
| control field |
102219 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
KnowledgeUnlatched |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20210303105118.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
cr u|||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
210129p20172019nkc o u00| u eng d |
| 037 ## - SOURCE OF ACQUISITION |
| Institution to which field applies |
BiblioBoard |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780813586496 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
| OCLC library identifier |
https://library.biblioboard.com/ext/api/media/51ada7ee-8b57-40bc-aa49-effc2488b433/assets/thumbnail.jpg |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
ScCtBLL |
| Transcribing agency |
ScCtBLL |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Walsh, Christine |
| Relator term |
author. |
| 245 00 - TITLE STATEMENT |
| Title |
Clinical Trials in Ovarian Cancer |
| Statement of responsibility, etc. |
Christine Walsh. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Name of producer, publisher, distributor, manufacturer |
Rutgers University Press, |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
1 online resource (337 p.) |
| 506 0# - RESTRICTIONS ON ACCESS NOTE |
| Terms governing access |
Access copy available to the general public. |
| Standardized terminology for access restriction |
Unrestricted |
| Source of term |
star |
| 520 ## - SUMMARY, ETC. |
| Summary, etc. |
The first book to collect and synthesize cutting-edge research findings on the treatment of gynecological malignancies into one easy-to-use reference, Clinical Trials in Ovarian Cancer provides physicians with an invaluable resource. Gynecologic oncologist Christine S. Walsh systematically outlines each of the seminal Phase III trials that have shaped the treatment of ovarian cancers, detailing the rationale for the trial, the patient population studied, treatment delivery methods, efficacy, toxicity, and trial conclusions. |
| 588 0# - SOURCE OF DESCRIPTION NOTE |
| Source of description note |
Description based on print version record. |
| 590 ## - LOCAL NOTE (RLIN) |
| Local note |
KU Select 2018: STEM Backlist Books |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Medical / Nursing |
| Source of heading or term |
bisacsh |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Medicine |
| 655 #0 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Electronic books. |
| 758 ## - |
| -- |
Is found in: |
| -- |
Knowledge Unlatched |
| -- |
https://openresearchlibrary.org/module/2774bc74-146a-484f-a7ba-ab1d6a09bbfb |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
| Uniform Resource Identifier |
<a href="https://openresearchlibrary.org/content/51ada7ee-8b57-40bc-aa49-effc2488b433">https://openresearchlibrary.org/content/51ada7ee-8b57-40bc-aa49-effc2488b433</a> |
| Public note |
View this content on Open Research Library. |
| -- |
0 |